Dietary fibre responses in microbiota reveal opportunity for disease-specific prebiotic approaches.

IF 3 4区 医学 Q2 MICROBIOLOGY
T Chen, T M Cantu-Jungles, B Zhang, T Yao, L Lamothe, M Shaikh, P A Engen, S J Green, A Keshavarzian, B R Hamaker
{"title":"Dietary fibre responses in microbiota reveal opportunity for disease-specific prebiotic approaches.","authors":"T Chen, T M Cantu-Jungles, B Zhang, T Yao, L Lamothe, M Shaikh, P A Engen, S J Green, A Keshavarzian, B R Hamaker","doi":"10.1163/18762891-bja00067","DOIUrl":null,"url":null,"abstract":"<p><p>Prebiotics or fermentable dietary fibres are known for their potential to shape the gut microbial community and could be used as a tool in treating gut dysbiotic states found in a wide range of diseases. However, it remains unclear whether the microbiota of individuals with distinct diseases respond to fibre treatments in the same way as healthy individuals do. In this study, a mechanistic understanding of fibre responses across health conditions was performed through in vitro faecal fermentations with various dietary fibres and faecal microbial communities from healthy individuals (HC) as well as Crohn's disease (CD), ulcerative colitis (UC), and Parkinson's disease (PD). Production of short chain fatty acids (SCFAs) was measured, and microbial community structure shifts were assessed using 16S rRNA gene amplicon sequencing. All tested dietary fibres increased short chain fatty acid production upon fermentation, with variations based on both, disease state and fibre type. The magnitude of shifts in microbial community structure resulting from in vitro fermentation varied by condition; for example, samples from individuals with UC responded weakly to fibre fermentation, while those from individuals with PD underwent dramatic changes. Still, each health condition had distinct fibre types that were more effective in shifting the community structure and increasing SCFAs. Overall, these results suggest that the response to fibres on gut microbiota varies by disease. The selection of disease-specific prebiotics could be tailored according to health conditions for optimal desired gut microbiota responses.</p>","PeriodicalId":8834,"journal":{"name":"Beneficial microbes","volume":" ","pages":"1-24"},"PeriodicalIF":3.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Beneficial microbes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1163/18762891-bja00067","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Prebiotics or fermentable dietary fibres are known for their potential to shape the gut microbial community and could be used as a tool in treating gut dysbiotic states found in a wide range of diseases. However, it remains unclear whether the microbiota of individuals with distinct diseases respond to fibre treatments in the same way as healthy individuals do. In this study, a mechanistic understanding of fibre responses across health conditions was performed through in vitro faecal fermentations with various dietary fibres and faecal microbial communities from healthy individuals (HC) as well as Crohn's disease (CD), ulcerative colitis (UC), and Parkinson's disease (PD). Production of short chain fatty acids (SCFAs) was measured, and microbial community structure shifts were assessed using 16S rRNA gene amplicon sequencing. All tested dietary fibres increased short chain fatty acid production upon fermentation, with variations based on both, disease state and fibre type. The magnitude of shifts in microbial community structure resulting from in vitro fermentation varied by condition; for example, samples from individuals with UC responded weakly to fibre fermentation, while those from individuals with PD underwent dramatic changes. Still, each health condition had distinct fibre types that were more effective in shifting the community structure and increasing SCFAs. Overall, these results suggest that the response to fibres on gut microbiota varies by disease. The selection of disease-specific prebiotics could be tailored according to health conditions for optimal desired gut microbiota responses.

膳食纤维在微生物群中的反应揭示了针对特定疾病的益生元方法的机会。
益生元或可发酵膳食纤维因其塑造肠道微生物群落的潜力而闻名,可作为治疗多种疾病中发现的肠道益生菌失调状态的工具。然而,目前尚不清楚患有不同疾病的个体的微生物群对纤维治疗的反应是否与健康个体相同。在这项研究中,通过对健康个体(HC)以及克罗恩病(CD)、溃疡性结肠炎(UC)和帕金森病(PD)的各种膳食纤维和粪便微生物群落进行体外粪便发酵,对纤维在健康状况下的反应机制进行了了解。测量短链脂肪酸(SCFAs)的产量,并使用16S rRNA基因扩增子测序评估微生物群落结构的变化。所有被测试的膳食纤维在发酵时都增加了短链脂肪酸的产量,根据疾病状态和纤维类型而有所不同。体外发酵引起的微生物群落结构变化幅度因条件而异;例如,UC患者的样品对纤维发酵的反应较弱,而PD患者的样品则发生了巨大的变化。尽管如此,每种健康状况都有不同的纤维类型,这些纤维类型在改变群落结构和增加scfa方面更有效。总的来说,这些结果表明,肠道菌群对纤维的反应因疾病而异。疾病特异性益生元的选择可以根据健康状况量身定制,以获得最佳所需的肠道微生物群反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Beneficial microbes
Beneficial microbes MICROBIOLOGY-NUTRITION & DIETETICS
CiteScore
7.90
自引率
1.90%
发文量
53
审稿时长
>12 weeks
期刊介绍: Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policy makers and regulators. The journal will have five major sections: * Food, nutrition and health * Animal nutrition * Processing and application * Regulatory & safety aspects * Medical & health applications In these sections, topics dealt with by Beneficial Microbes include: * Worldwide safety and regulatory issues * Human and animal nutrition and health effects * Latest discoveries in mechanistic studies and screening methods to unravel mode of action * Host physiology related to allergy, inflammation, obesity, etc. * Trends in application of (meta)genomics, proteomics and metabolomics * New developments in how processing optimizes pro- & prebiotics for application * Bacterial physiology related to health benefits
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信